These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 667880)

  • 1. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ; Baer L; Radichevich I
    Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 5. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
    Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II blockade in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):61-3. PubMed ID: 1071407
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W
    Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract]   [Full Text] [Related]  

  • 8. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P; Donker AJ; Leenen FH
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering of hypertension by central saralasin in the absence of plasma renin.
    Phillips MI; Mann JF; Haebara H; Hoffman WE; Dietz R; Schelling P; Ganten D
    Nature; 1977 Dec; 270(5636):445-7. PubMed ID: 593364
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin blockade: its clinical significance.
    Streeten DH; Anderson GH; Dalakos TH
    Am J Med; 1976 May; 60(6):817-24. PubMed ID: 1020761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of renin in the hypertensive patient.
    Brunner HR; Gavras H
    JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of an angiotensin antagonist on blood pressure, renin and aldosterone secretion and its pathogenetic importance].
    Beckerhoff R
    Schweiz Med Wochenschr Suppl; 1978; (7):1-24. PubMed ID: 349683
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma.
    Röckel A; Heidland A; Appel E; Palm D
    N Engl J Med; 1977 Jan; 296(1):50-1. PubMed ID: 830274
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Hypotension during angiotensin blockade with saralasin.
    Pettinger WA; Keeton K
    Lancet; 1975 Jun; 1(7921):1387-8. PubMed ID: 48980
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II blockade in hypertensive dialysis patients.
    MacGregor GA; Dawes PM
    Prog Biochem Pharmacol; 1976; 12():190-9. PubMed ID: 1019164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive effects of angiotensin blockade: saralasin versus captopril.
    Baker KM; Johns DW; Vaughan ED; Ayers CR; Carey RM
    Clin Exp Hypertens (1978); 1980; 2(6):947-54. PubMed ID: 7004807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.